US Court Dismisses Teva Case to Block Generic Copaxone

16.05.2014 - Shortly before expiration of the patent on the multiple sclerosis treatment Copaxone, a US district court has dismissed a case by Teva Pharmaceutical Industries, subsidiary of the...